12:00 AM
Sep 07, 2000
 |  BC Extra  |  Clinical News

Therion begins two Phase II trials

Under a CRADA, Therion ( Cambridge, Mass.) and the National Cancer Institute began two additional Phase II trials of Prostvac VF, a live recombinant vaccine consisting of...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >